I am a healthcare professional
If you are a healthcare professional looking to find out more about heavy menstrual bleeding and contraception, please click below.
HCP

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Bayer logo

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Bayer in women's health

For almost a century, Bayer has been working to make a positive difference to women’s health through pioneering research and innovation.

In the 1920s, Bayer—then called Schering AG—made a significant contribution to understanding the molecular structure of sex hormones and launched the world's first oestrogen preparation for menopause management. This firmly set Bayer as a pioneer in women’s healthcare and, in 1961, Bayer became the first company to launch a contraceptive pill in Europe, the combined oral contraceptive Anovlar® (norethisterone acetate/ethinylestradiol)1

Bayer timeline

More recent innovations include the introduction of Kyleena® (19.5 mg intrauterine delivery system levonorgestrel) a low-dose, levonorgestrel-releasing intrauterine delivery system which was launched in the UK in 2018.2

  1. Pletzer BA and Kerschbaum HH. Front Neurosci 2014;8:256.
  2. Kyleena – Europe 2018 – prescribing information - Reference ID: 4228507. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208224s001lbl.pdf [Last accessed: November 2019].

Just like you, we care about women’s health...

In the 1960’s, we were the first to launch the contraceptive pill in Europe, giving women more power to choose their own future. Today, we continue to work with women and their clinicians to understand what really matters and where our expertise can help.

slider-image-1

You’re a lifelong learner.
So are we.

Whether you want to master new procedures or join the conversation driving innovation in women’s health, we can help.

slider-image-2

You care about delivering the best care. So do we.

We’re always looking for ways to help you to help your patients. At Bayer, we’re beside you all the way.

slider-image-3

Bayer’s innovations in women’s health timeline:

1960

First European birth control pill, the combined oral contraceptive Anovlar® (norethisterone/ethinyl estradiol)

Progestogen-only pill (mini-pill)

First levonorgestrel-releasing IUS, Mirena® (52 mg intrauterine delivery system), launched in the UK in 19951

First progestogen-only emergency contraception, Levonelle® (levonorgestrel) launched in the UK

First low-estrogen dose contraceptive pill, Yasmin® (ethinylestradiol/drospirenone)

First pill to treat premenstrual dysphoric disorder, a severe form of premenstrual syndrome, in the US for women who choose the contraceptive pill for birth control.

Jaydess® (13.5 mg intrauterine delivery system levonorgestrel) was launched in 2014

First oral contraceptive pill to contain the oestrogen estradiol valerate, an oestrogen that is immediately converted to estradiol in a woman’s body, Qlaira® (estradiol valerate/dienogest)2

First birth control pill approved for the treatment of heavy menstrual bleeding, Qlaira®

Kyleena® (19.5 mg intrauterine delivery system levonorgestrel), a low-dose levonorgestrel-releasing IUS was launched in the UK in 2018

Present day

  1. Costescu DJ. Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling. Int J Womens Health. 2016;8:589–598. Published 2016 Oct 13. doi:10.2147/IJWH.S99705
  2. Bayer Plc. Qlaira, film-coated tablets: Summary of Product Characteristics [online]. Updated 17 December 2018. Available from: https://www.medicines.org.uk/emc/product/6536 [Last accessed: August 2019].

Bayer offers a number of contraception methods for women, depending on their personal needs. These include:

Qlaira®

(estradiol valerate/dienogest)

is a combined oral contraceptive approved for the treatment of menorrhagia1

Qlaira

Mirena®

52 mg levonorgestrel-releasing intrauterine system

is an IUS indicated for contraceptive use for up to 5 years, as a treatment option for idiopathic menorrhagia for up to 5 years and as protection from endometrial hyperplasia during oestrogen replacement therapy for up to 4 years2

Mirena

Kyleena®

19.5 mg Intrauterine delivery system levonorgestrel

is an IUS indicated for contraceptive use for up to 5 years3

Klyeena

  1. Bayer Plc. Qlaira® (estradiol valerate/dienogest): Summary of Product Characteristics [online]. Updated 17 December 2018]. Available from: https://www.medicines.org.uk/emc/product/6536/smpc [Last accessed: August 2019].
  2. Bayer Plc. Mirena® (52 mg intrauterine delivery system levonorgestrel): Summary of Product Characteristics [online]. Updated 17 October 2019. Available from: https://www.medicines.org.uk/emc/product/1132 [Last accessed: August 2019].
  3. Bayer Plc. Kyleena® (19.5 mg intrauterine delivery system levonorgestrel): Summary of Product Characteristics [online]. Updated 02 May 2019. Available from: https://www.medicines.org.uk/emc/product/769 [Last accessed: August 2019].

Recommendations

Upcoming webinars

Read more

Mirena®

Read more

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk. Adverse events should also be reported to Bayer plc Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.


If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: qualitycomplaints@bayer.com For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.

  • PP-PF-WHC-GB-0259 November 2019

Copyright © 2019,
Bayer plc

This website is intended for UK healthcare professionals only. Women’s Health Matters is organised and funded by Bayer and contains promotional content.

Prescribing Information (PI) can be found via the links below:
Mirena® (52 mg intrauterine delivery system Levonorgestrel)
Kyleena® (19.5 mg intrauterine delivery system Levonorgestrel)
Jaydess® (13.5 mg intrauterine delivery system Levonorgestrel)
Qlaira® (estradiol valerate/dienogest)
Microgynon® (levonorgestrel/ethinylestradiol)

Page last modified Tue, 08/18/2020 - 07:37

Bayer logo